Navigation Links
Tag-It Cystic Fibrosis ASPE Mix B

ProductsTag-It Cystic Fibrosis ASPE Mix B
Company Tm Bioscience Corporation
Item Tag-It Cystic Fibrosis ASPE Mix B
Features Inquire
Description The Tag-It™ Cystic Fibrosis ASR reagents can be used by high complexity CLIA approved laboratories for detection of up to 70 mutations and 6 variants (polymorphisms) in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
Info Tm Bioscience Corporation
Customer Service: (416) 593-4323
Web site: http://www.tmbioscience.com

Related medicine products :

1. Tag-It Cystic Fibrosis PCR Mix
2. Tag-It Cystic Fibrosis PCR Mix B
3. Tag-It Cystic Fibrosis ASPE Mix
4. Tag-It™ Cystic Fibrosis Kit
5. Appel-Berci Cystic Duct Introducer Sets
6. Culture, Cystic Respiratory
7. Cystic Fibrosis 3199del6 Only(ARUP Medical Director or Genetic Counselor approval required prior to testing)
8. Cystic Fibrosis, Atypical
9. Cystic Fibrosis Cis-Trans
10. Cystic Fibrosis, Mutation Panel, Fetal
11. Cystic Fibrosis, MutationPanel
Breaking Medicine News(10 mins):Health News:You Never Get a Second Chance to Make a First Impression: High-Definition for the Web 2Health News:Moravia Worldwide to Present Live Webinar on Creation and Use of Terminology in Localization 2Health News:Moravia Worldwide to Present Live Webinar on Creation and Use of Terminology in Localization 3Health News:Lung Cancer Alliance Praises Growing National Coalition 2Health News:Lung Cancer Alliance Praises Growing National Coalition 3Health News:Book Offers Help for Parents Struggling with Difficult Teens During the Upcoming Holidays 2Health News:Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009 2Health News:Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009 3Health News:Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009 4
Breaking Medicine Technology:Reportlinker Adds Medical Fiber Optics - A World Market Analysis 2Reportlinker Adds Medical Fiber Optics - A World Market Analysis 3Reportlinker Adds Medical Fiber Optics - A World Market Analysis 4Reportlinker Adds Medical Fiber Optics - A World Market Analysis 5Reportlinker Adds Medical Fiber Optics - A World Market Analysis 6Reportlinker Adds US Home Healthcare Equipment & Services Market: An Analysis 2Reportlinker Adds US Home Healthcare Equipment & Services Market: An Analysis 3Reportlinker Adds US Home Healthcare Equipment & Services Market: An Analysis 4Reportlinker Adds US Home Healthcare Equipment & Services Market: An Analysis 5Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 2Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 3Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 4Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 5Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 6Reliv International Launches New Products and Business Tools at 21st International Conference 54781 1Reliv International Launches New Products and Business Tools at 21st International Conference 54781 2Reliv International Launches New Products and Business Tools at 21st International Conference 54781 3Johnson City Medical Center Saves 24550 000 with Smart Square 28R 29 54778 1Johnson City Medical Center Saves 24550 000 with Smart Square 28R 29 54778 2What Oklahomans Should Know About Cataract Surgery 54775 1What Oklahomans Should Know About Cataract Surgery 54775 2What Oklahomans Should Know About Cataract Surgery 54775 3